-
The FDA has approved an extended-release, once-daily, dipeptidyl-4 (DPP-4) inhibitor in combination with metformin for adults with type 2 diabetes. Janumet XR combines sitagliptin and metformin. The new combination is the second such product joining Kombiglyze XR, which combines saxagliptin and metformin. Janumet XR is marketed by Merck & Co., Inc.
-
Rapid influenza diagnostic tests have modest sensitivity and high specificity.
-
A retrospective survey of 744 Dutch and Belgian travelers who had ventured to 2500 m (8200 feet) or higher revealed that 25% developed acute mountain sickness. Only half of this group had followed pre-travel advice regarding altitude sickness, and few took preventive acetazolamide.
-
-
Scenario: Interpret the lead MCL-1 rhythm strip shown above. Can you explain the irregularity?
-
The lifetime risk of cardiovascular disease is strongly influenced by risk factor burden and may be similar across race and birth cohorts.
-
A new topical preparation for the treatment of head lice has been approved by the FDA. Ivermectin is a macrocyclic lactone antibiotic that has been used orally both on and off label for head lice since 2001.
-
Infants in an area with high malaria exposure were infected with EBV at a significantly younger age in infancy, with a much higher incidence of primary EBV infection before 6 months of age.
-
A total of 153 nasopharyngeal swabs were collected as part of a nationwide study in Switzerland from children <2 years of age treated for acute otitis media from 2004-2009.
-
Classically, pneumonia is defined as an infection of the lung parenchyma. However, worldwide, a variety of definitions exist, including fever, hypoxia, a constellation of other clinical symptoms, and radiologic findings. In pediatric and adolescent populations, early diagnosis will assist emergency department (ED) physicians with correctly managing and subsequently avoiding potential morbidity and mortality of this common infectious disease.
